StemCells stemcellsinc.com


Public lists: Neuroscience Startups (947)

StemCells (NASDAQ: STEM) is engaged in clinical development of its proprietary HuCNS-SC (purified human neural stem cells) platform technology to treat diseases of the human central nervous system (CNS).

StemCells (NASDAQ: STEM) is engaged in clinical development of its proprietary HuCNS-SC (purified human neural stem cells) platform technology to treat diseases of the human central nervous system (CNS).

Company (IPO / Went public)

Phone: 650-670-2282

Fax:

39899 Balentine Drive
Ste 200
Newark, 94560
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
StemCells $20M Jul 19, 2004

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related StemCells Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 27 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cultures of gfap Dec 23, 2009 Aug 06, 2013 Patent
Liver engrafting cells, assays, and uses thereof Aug 10, 2010 Oct 09, 2012 Patent
Human liver engrafting cells isolated from adult liver tissue Aug 09, 2006 Oct 12, 2010 Patent